Isabel Delany,1
Gunther Spohn,1,
Rino Rappuoli,1 and
Vincenzo Scarlato1,2*
Biochemistry and Molecular Biology Unit, Chiron Vaccines, 53100 Siena,1 Department of Biology, University of Bologna, 40126 Bologna, Italy2
Received 19 November 2004/ Accepted 2 February 2005
The crgA gene of Neisseria meningitidis, which codes for a LysR-type regulator, is divergently oriented with respect to the mdaB gene, which codes for a hypothetical NADPH-quinone oxidoreductase. Transcriptional studies of the intergenic region between crgA and mdaB showed that two overlapping and divergent promoters, PcrgA and PmdaB, control transcription of these genes. Deletion of the crgA gene led to a strong increase in transcription from the PcrgA promoter and a concomitant strong decrease in transcription from the PmdaB promoter, indicating that CrgA acts both as an autorepressor of transcription at its own promoter and as an activator of transcription at the mdaB promoter. Addition of
-methylene-
-butyrolactone (MBL), an inducer of NADPH-quinone oxidoreductase, to wild-type N. meningitidis cells specifically resulted in further activation of transcription of the PmdaB promoter and more repression of transcription of the PcrgA promoter. No such regulation was observed when MBL was added to crgA-deficient cells, indicating that the transcriptional response to MBL is CrgA mediated. Under the same experimental conditions, no regulation of transcription by either CrgA or MBL was detected at the pilus and capsule genes. The role of CrgA in the regulation of gene expression during the infectious cycle of N. meningitidis is discussed.
Present address: Institute of Microbiology, ETH-Hönggerberg HCI 4, Wolfgang-Pauli-Strasse, CH-8093 Zurich, Switzerland.
Present address: Cytos Biotechnology, Wagistrasse 25, CH-8952 Zurich-Schlieren, Switzerland.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |